VIVOS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.59 USD | +5.28% |
|
-4.78% | -79.18% |
| 04-01 | Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures | MT |
| 04-01 | Top Premarket Decliners | MT |
Chart calendar Vivos Therapeutics, Inc.
5e7e8e08d3.SSaMeKYvujaUoXbOrPC5Ivngg9q2ScmN3sajKKnGIec.fXDhSPFi10HixjKPyIrjTo2O6ZXcH6LYlJPQbO6xEYEwXMss0GTucsDHMw~aad8bbb0814391ed5ef7156e39f381f0
Upcoming events on Vivos Therapeutics, Inc.
Past events on Vivos Therapeutics, Inc.
| 28/03/2024 21:00 | Q4 2023 Earnings Call |
| 28/03/2024 20:05 | Q4 2023 Earnings Release |
| 31/01/2024 | Empowering Women to Champion Airway Conference |
| 14/11/2023 22:00 | Q3 2023 Earnings Call |
| 14/11/2023 21:05 | Q3 2023 Earnings Release |
| 21/09/2023 | Annual General Meeting |
| 16/08/2023 23:00 | Q2 2023 Earnings Call |
| 16/08/2023 21:05 | Q2 2023 Earnings Release |
| 08/06/2023 22:00 | Q1 2023 Earnings Call |
| 08/06/2023 21:05 | Q1 2023 Earnings Release |
| 30/03/2023 22:00 | Q4 2022 Earnings Call |
| 30/03/2023 21:05 | Q4 2022 Earnings Release |
| 14/03/2023 20:30 | ROTH Conference |
| 22/02/2023 17:35 | Emerging Growth Conference |
| 20/12/2022 22:00 | Q3 2022 Earnings Call |
| 20/12/2022 21:15 | Q3 2022 Earnings Release |
| 25/10/2022 | Breathing Wellness Conference |
| 24/08/2022 | Annual General Meeting |
| 15/08/2022 22:00 | Interim 2022 Earnings Call |
| 14/08/2022 | Interim 2022 Earnings Release After hours |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13,1 12,9 0.99% | 16,9 17,3 -2.4% | 16,0 16,5 -3.17% | 13,8 14,0 -1.3% | 16,1 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -24,4 -24,4 0.16% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,71 -7,72 -12.76% | -20,4 -18,2 -12.01% | -25,0 -23,8 -5.22% | -17,3 -16,4 -5.42% | -10,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,1 -7,90 -52.62% | -20,3 -18,2 -11.76% | -23,8 -22,6 -5.63% | -13,6 -12,5 -8.98% | -10,7 |
|
Net income Million USD | Released Forecast Spread | -18,0 -7,90 -127.69% | -20,3 -18,2 -11.76% | -23,8 -22,6 -5.63% | -13,6 -12,5 -8.98% | -10,7 |
|
EPS USD | Released Forecast Spread | -35,0 -11,8 -197.87% | -24,0 -22,5 -6.67% | -26,0 -26,5 1.89% | -11,1 -9,55 -16.65% | -3,95 |
| Announcement Date | 25/03/21 | 31/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,39 4,85 -9.47% | 3,46 4,44 -22.11% | 4,25 | 3,95 4,55 -13.26% | 3,86 4,01 -3.73% | 3,40 4,12 -17.53% | 3,30 4,50 -26.64% | 3,25 3,41 -4.64% | 3,50 | 3,80 | 4,30 | 4,50 | 4,10 |
|
EBITDA Million USD | Released Forecast Spread | -5,89 -4,90 -20.29% | -4,37 -4,30 -1.6% | -3,34 -3,70 9.76% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -7,41 -5,26 -40.87% | -6,82 -5,67 -20.37% | -5,41 | -6,06 -4,69 -29.2% | -5,01 -5,39 7.2% | -4,52 -4,30 -4.97% | -3,49 -3,60 3.08% | -4,28 -3,40 -25.94% | -3,10 | -2,80 | -2,40 | -2,30 | -2,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,39 -5,26 -40.66% | -5,52 -5,66 2.57% | -5,43 | -6,09 -4,70 -29.48% | -1,70 -5,41 68.51% | -5,53 -4,32 -28.02% | -2,09 -3,60 41.86% | -4,26 -3,15 -35.14% | -3,10 | -2,80 | -2,40 | -2,30 | -2,50 |
|
Net income Million USD | Released Forecast Spread | -7,39 -5,26 -40.66% | -5,52 -5,66 2.57% | -5,43 | -6,09 -4,70 -29.48% | -1,70 -5,41 68.51% | -5,53 -4,32 -28.02% | -2,09 -3,60 41.86% | -4,26 -3,15 -35.14% | -3,10 | -2,80 | -2,40 | -2,30 | -2,50 |
|
EPS USD | Released Forecast Spread | -8,50 -6,25 -36% | -6,50 -6,50 0% | -6,50 | -5,00 -5,50 9.09% | -1,75 -4,25 58.82% | -4,50 -3,63 -24.14% | -1,75 -3,00 41.67% | -3,05 -1,91 -60.1% | -1,16 | -1,05 | -0,89 | -0,85 | -0,92 |
| Announcement Date | 31/03/22 | 16/05/22 | 20/12/22 | 30/03/23 | 08/06/23 | 16/08/23 | 14/11/23 | 28/03/24 | - | - | - | - | - |
| 29/04/2024 | INARI MEDICAL, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | IRADIMED CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | NOVOCURE LIMITED: Q1 2024 Earnings Release |
| 05/05/2024 | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
| 06/05/2024 21:09 | SI-BONE, INC.: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | CHEMOMETEC A/S: Q3 2024 Earnings Release |
| 08/05/2024 | WON TECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
Past sector events for Vivos Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VVOS Stock
- Calendar Vivos Therapeutics, Inc.
